Side-by-side financials for DARE and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DARE | LLY |
|---|---|---|
| Market cap | - | $1.070 T |
| US-listed rank | - | #10 |
| Revenue (latest FY) | $1.03M | $65.18B |
| Net income (latest FY) | -$13.40M | $20.64B |
| Net margin | -1300.7% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 740 | 989 |
In their latest fiscal years, Dare Bioscience, Inc. reported $1.03M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Dare Bioscience, Inc. and ELI LILLY & Co, or browse the full rankings.